The present invention discloses a multiplexed microfluidic assay device [300] for the simultaneous detection of biomarkers such as serum lipase, serum amylase, and urinary or serum trypsinogen-2. The device [300] comprises two distinct zones, i.e., Zone 1 [100], a colorimetric enzymatic assay zone for detecting seru...